GT Biopharma Market Cap

GT Biopharma has a market cap or net worth of $6.79 million as of June 11, 2024. Its market cap has decreased by -37.10% in one year.

Market Cap

6.79M

Enterprise Value

-2.98M

1-Year Change

-37.10%

Ranking

#5358

Market Cap Chart

Since March 27, 2018, GT Biopharma's market cap has decreased from $83.20M to $6.79M, a decrease of -91.83%. That is a compound annual growth rate of -33.19%.

Market Cap History

Date	Market Cap	% Change
Jun 10, 2024	4.00M	-11.11%
Jun 7, 2024	4.50M	-2.17%
Jun 6, 2024	4.60M	-4.17%
Jun 5, 2024	4.80M	-4.00%
Jun 4, 2024	5.00M	-1.96%
Jun 3, 2024	5.10M	-3.77%
May 31, 2024	5.30M	-3.64%
May 30, 2024	5.50M	10.00%
May 29, 2024	5.00M	-
May 28, 2024	5.00M	-3.85%
May 24, 2024	5.20M	-5.45%
May 23, 2024	5.50M	-22.54%
May 22, 2024	7.10M	-10.13%
May 21, 2024	7.90M	-28.18%
May 20, 2024	11.00M	150.00%
May 17, 2024	4.40M	-4.35%
May 16, 2024	4.60M	6.98%
May 15, 2024	4.30M	-2.27%
May 14, 2024	4.40M	-2.22%
May 13, 2024	4.50M	-2.17%
May 10, 2024	4.60M	2.22%
May 9, 2024	4.50M	4.65%
May 8, 2024	4.30M	-4.44%
May 7, 2024	4.50M	2.27%
May 6, 2024	4.40M	-4.35%

View and export this data all the way back to 2018. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
TransCode Therapeutics	7.23M
PolyPid	7.21M
Pulmatrix	7.20M
Cyclerion Therapeutics	6.91M
NuCana	6.83M
BioCardia	6.77M
Tenax Therapeutics	6.76M
Entero Therapeutics	6.72M

Market Cap Rankings